Pathogenesis and management of obesity

Consultations in Feline Internal Medicine

Volumn , Issue , 2006, Pages 175-182

  Hoenig, Margarethe ^a   Rand, Jacquie S ^b  

^a UNIVERSITY OF GEORGIA   (United States)

^b Humane Society of the United States   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84882431130     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B0-72-160423-4/50022-6     Document Type: Chapter

References (72)

1. Scarlett JM, Donoghue S, Saidla J, et al. Overweight cats: prevalence and risk factors. Int J Obes Relat Metab Disord 1994, 18:S22-S28.
2. Spiegelman BM, Flier JS Obesity and the regulation of energy balance. Cell 2001, 104:531-543.
3. Kopelman PG Obesity as a medical problem. Nature 2000, 404:635-643.
4. Hoenig M Comparative aspects of diabetes mellitus in dogs and cats. Mol Cell Endocrinol 2002, 197:221-229.
5. Poirier P, Eckel RH Obesity and cardiovascular disease. Curr Atheroscler Rep 2002, 4:448-453.
6. Hoenig M, Wilkins C, Holson JC, et al. Effects of obesity on lipid profiles in neutered male and female cats. Am J Vet Res 2003, 64:299-303.
7. Watson TDG, Butterwick RF, McConnell M, et al. Development of methods for analyzing plasma lipoprotein concentrations and associated enzyme activities and their use to measure the effects of pregnancy and lactation in cats. Am J Vet Res 1995, 56:289-296.
8. Ginzinger DG, Clee SM, Dallongeville J, et al. Lipid and lipoprotein analysis of cats with lipoprotein lipase deficiency. Europ J Clin Invest 1999, 2:17-26.
9. LaFlamme DP Development and validation of a body score system for cats. A clinical tool. Fel Pract 1997, 25:13-17.
10. Nelson R, Himsel C, Feldman E, et al. Glucose tolerance and insulin response in normal-weight and obese cats. Am J Vet Res 1990, 51:1357-1362.
11. Wilkins C, Long RC, Waldron M, et al. Assessment of the influence of fatty acids on indices of insulin sensitivity and myocellular lipid content by use of magnetic resonance spectroscopy in cats. Am J Vet Res 2004, 65:1090-1099.
12. O'Brien TD, Hayden DW, Johnson KH High dose intravenous glucose tolerance test and serum insulin and glucagon levels in diabetic and non-diabetic cats: relationships to insular amyloidosis. Vet Pathol 1985, 22:250-261.
13. Nelson RW, Himsel CA, Feldman EC Glucose tolerance and insulin response in normal weight and obese cats. Am J Vet Res 1990, 51:1357-1362.
14. Lutz TA, Rand JS Plasma amylin and insulin concentrations in normoglycemic and hyperglycemic cats. Can Vet J 1996, 37:27-34.
15. Hoenig M, Alexander S, Holson J, et al. Influence of glucose dosage on interpretation of intravenous glucose tolerance tests in lean and obese cats. J Vet Intern Med 2002, 16:529-532.
16. Curry DL, Morris JG, Rogers QR, et al. Dynamics of insulin and glucagon secretion by the isolated perfused cat pancreas. Comp Biochem Physiol A 1982, 72:333-338.
17. Del Prato S, Tiengo A The importance of first-phase insulin secretion: implications for the therapy of type 2 diabetes mellitus. Diabetes Metab Res Rev 2001, 17:164-174.
18. Haffner SM, Gonzalez C, Mykkänen L, et al. Total immunoreactive proinsulin, immunoreactive insulin and specific insulin in relation to conversion to NIDDM: the Mexico City Diabetes Study. Diabetologia 1997, 40:830-837.
19. Wareham NJ, Byrne CD, Williams R, et al. Fasting proinsulin concentrations predict the development of type 2 diabetes. Diabetes Care 1999, 22:262-270.
20. Olson AL, Pessin JE Structure, function, and regulation of the mammalian facilitative glucose transporter gene family. Annu Rev Nutr 1996, 16:235-256.
21. DeFronzo RA, Ferrannini E Insulin resistance. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease. Diabetes Care 1991, 14:173-194.
22. Brandao J, Thomasseth K, Ferguson DC, et al: Euglycemic hyperinsulinemic clamp and [ 3H]-glucose kinetics in lean and obese cats. Proc 18 th Forum Am Coll Vet Intern Med, Minneapolis, 2004, p A71.
23. Brennan C, Ferguson DC, Hoenig M GLUT4 but not GLUT1 expression decreases early in the development of feline obesity. Domest Anim Endocrinol 2004, 26:291-301.
24. Boden G Effects of free fatty acids (FFA) on glucose metabolism: significance for insulin resistance and type 2 diabetes. Exp Clin Endocrinol Diabetes 2003, 111:121-124.
25. Bell KS, Schmitz-Pfeiffer C, Lim-Fraser M, et al. Acute reversal of lipid-induced muscle insulin resistance is associated with rapid alteration in PKC-theta localization. Am J Physiol Endocrinol Metab 2000, 279:E1196-E1201.
26. McGarry JD Banting lecture 2001: dysregulation of fatty acid metabolism in the etiology of type 2 diabetes. Diabetes 2001, 51:7-18.
27. Hoenig M, Ferguson DC Effect of darglitazone on glucose clearance and lipid metabolism in obese cats. Am J Vet Res 2003, 64:1409-1413.
28. Escher P, Braissant O, Basu-Modak S Rat PPARs: quantitative analysis in adult rat tissues and regulation in fasting and refeeding. Endocrinology 2001, 142:4195-4202.
29. Saltiel AR, Olefsky JM Thiazolidinediones in the treatment of insulin resistance and type II diabetes. Diabetes 1996, 45:1661-1669.
30. Matsuda J, Hosoda K, Itoh H, et al. Increased adipose expression of the uncoupling protein-3 gene by thiazolidinediones in Wistar fatty rats and in cultured adipocytes. Diabetes 1998, 47:1809-1814.
31. Camirand A, Marie V, Rabelo R, et al. Thiazolidinediones stimulate uncoupling protein-2 expression in cell lines representing white and brown adipose tissues and skeletal muscle. Endocrinology 1998, 139:428-431.
32. Hoenig M, MacGregor LC, Matschinsky FM In vitro exhaustion of pancreatic beta-cells. Am J Physiol Endocrinol Metab 1986, 250:E502-E511.
33. Prentki M, Joly E, El-Assaad W Malonyl-CoA signaling, lipid partitioning, and glucolipotoxicity: role in beta-cell adaptation and failure in the etiology of diabetes. Diabetes 2002, 51(suppl 3):S405-S413.
34. Hoenig M, Hall G, Ferguson DC, et al. A feline model of experimentally induced islet amyloidosis. Am J Pathol 2000, 157:2143-2150.
35. Jordan K, Murtaugh MP, O'Brien TD, et al. Canine IAPP cDNA sequence provides important clues regarding diabetogenesis and amyloidogenesis in type 2 diabetes. Biochem Biophys Res Commun 1990, 169:502-508.
36. Butler AE, Jang J, Gurlo T, et al. Diabetes due to a progressive defect in beta-cell mass in rats transgenic for human islet amyloid polypeptide (HIP Rat): a new model for type 2 diabetes. Diabetes 2004, 53:1509-1516.
37. Hoenig M: Obesity in the cat. Proceedings of the 18 th ACVIM Forum, Seattle, 2000, pp 662-663.
38. Appleton DJ, Rand JS, Sunvold GD Plasma leptin concentrations are independently associated with insulin sensitivity in lean and overweight cats. J Feline Med Surg 2002, 4:83-93.
39. Broemel C: Determination of adiponectin, a novel adipocyte hormone in healthy and diabetic normal weight and obese cats. Proceedings of the 21 st ACVIM Forum 2004, Minneapolis, A69.
40. Frayn KN, Karpe F, Fielding BA, et al. Integrative physiology of human adipose tissue. Int J Obes Relat Metab Disord 2003, 27:875-888.
41. Banks WA, Coon AB, Robinson SM, et al. Triglycerides induce leptin resistance at the blood-brain barrier. Diabetes 2004, 53:1253-1260.
42. Stefan N, Stumvoll M Adiponectin-its role in metabolism and beyond. Horm Metab Res 2002, 34:469-474.
43. Nelson RW, Griffey SM, Feldman EC, et al. Transient clinical diabetes mellitus in cats: 10 cases (1989-1991). J Vet Intern Med 1999, 13:28-35.
44. Scarlett JM, Donoghue S Associations between body condition and disease in cats. J Am Vet Med Assoc 1998, 11:1725-1731.
45. Kealy RD, Lawler DF, Ballam JM, et al. Effects of diet restriction on life span and age-related changes in dogs. J Am Vet Med Assoc 2002, 9:1315-1320.
46. Giles R, Gruffydd-Jones T, Sturgess C: A preliminary investigation into the effect of different strategies for achieving weight loss in cats. In Proc 46th Annual Congress Brit Small Anim Vet Assoc Birmingham, UK, 2003 (abstract).
47. Trippany JR, Funk JB: Effects of environmental enrichments on weight loss in cats. In Proc 21 st Am Coll Vet Intern Med Forum, 2003.
48. Lederer R, Rand JS, Markwell PJ: Chronic or recurring medical problems, dental disease, repeated corticosteroid treatment, and lower physical activity are associated with diabetes in Burmese cats. In Proc 21 st Am Coll Vet Intern Med Forum, 2003 (abstract).
49. Burkholder WJ, Toll PW Obesity. Small animal clinical nutrition 2000, 409. Mark Morris Institute, Kansas. ed 4. M.S. Hand, C.D. Thatcher, R.L. Remillard (Eds.).
50. Kolotkin RL, Crosby RD, Williams GR, et al. The relationship between health-related quality of life and weight loss. Obes Res 2001, 9:564-571.
51. Remillard RL Clinical aspects of obesity management 2000, In Proc Purina Nutr Forum, St Louis.
52. Martin G, Rand J Food intake and blood glucose in normal and diabetic cats fed ad libitum. J Feline Med Surg 1999, 4:241-251.
53. Macdonald M, Rogers Q, Morris J Nutrition of the domestic cat: a mammalian carnivore. Ann Rev Nutr 1984, 4:521-562.
54. Farrow HA, Rand JS, Sunvold GD: The effect of high protein, high fat or high carbohydrate diets on post-prandial glucose and insulin concentrations in normal cats. In Proc 20 th Am Coll Vet Intern Med Forum, 2002.
55. Farrow HA, Rand JS, Sunvold G: Effect of feeding pattern on insulin and glucose concentration in cats. In Pro 21 st Am Coll Vet Intern Med Forum, 2003, p 999 (abstract).
56. Hoenig M, Alexander S, Pazak H Effect of a high and low protein diet on glucose metabolism and lipids in the cat 2000, In Proc Purina Nutr Forum, St Louis, .
57. Holt SHA, Brand Miller J Increased insulin responses to ingested foods are associated with lessened satiety. Appetite 1995, 24:43-54.
58. Zoran DL The carnivore connection to nutrition in cats. J Am Vet Med Assoc 2002, 11:1559-1567.
59. Appleton DJ, Rand JS, Priest J, et al. Dietary carbohydrate source affects glucose concentrations, insulin secretion and food intake in overweight cats. Nutr Res 2004, 24(6):447-467.
60. Center SA, Harte J, Watrous D, et al. The clinical and metabolic effects of rapid weight loss in obese pet cats and the influence of supplemental oral L-carnitine. J Vet Intern Med 2000, 14:598-608.
61. Anderson RA Chromium metabolism and its role in disease processes in man. Clin Physiol Biochem 1986, 4:31-41.
62. Anderson RA, Kozlovsky AS Chromium intake, absorption and excretion of subjects consuming self-selected diets. Am J Clin Nutr 1985, 41:1177-1183.
63. Brown RO, et al. Chromium deficiency after long-term total parenteral nutrition. Digest Dis Sci 1986, 6:661-664.
64. Freund H, Atamian S, Fischer JE Chromium deficiency during total parenteral nutrition. JAMA 1979, 241:496-498.
65. Jeejeebhoy KN, et al. Chromium deficiency glucose intolerance and neuropathy reversed by chromium supplementation in a patient receiving long-term total parenteral nutrition. Am J Clin Nutr 1977, 30:531-538.
66. Spears JW, et al. Influence of chromium on glucose metabolism and insulin sensitivity. Recent advances in canine and feline nutrition, vol 2. 1998 Iams nutrition symposium proceedings 1998, 103-113. Orange Frazer Press, Ohio. G.A. Reinhart, D.P. Carey (Eds.).
67. Appleton DJ, Rand JS, Sunvold GD, et al. Dietary chromium tripicolinate supplementation reduces glucose concentrations and improves glucose tolerance in normal-weight cats. J Feline Med Surg 2002, 4:13-25.
68. Puigserver P, Vazquez F, Bonet ML, et al. In vitro and in vivo induction of brown adipocyte uncoupling protein (thermogenin) by retinoic acid. Biochem J 1996, 317:827-833.
69. Nelson R, Scott-Moncrieff C, Devries S, et al: Dietary insoluble fiber and glycemic control of diabetic cats. In Proc 12 th Am Coll Vet Intern Med Forum, San Francisco, 1994, p 996 (abstract).
70. Massimino SP, et al. Fermentable dietary fiber increases GLP-1 secretion and improves glucose homeostasis despite increased intestinal glucose transport capacity in healthy dogs. J Nutr 1998, 128:1786-1793.
71. Naslund E, et al. Glucagon-like peptide 1 increases the post-prandial satiety and slows gastric emptying in obese men. Am J Clin Nutr 1998, 68:524-530.
72. Center SA Obesity: how to make weight loss happen in the dog and cat. The role of nutrition in weight management 2003, 9-20. In Proc North Am Vet Conf, Orlando, Fla.